IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q3 FY24 results · Oct–Dec 2023
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹520.39 crore (down 0.6% from Q3 FY23) and net profit of ₹23.08 crore (down 3.0% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 520.39 | 523.48 | −0.6% | 545.30 | −4.6% |
| Other income | 8.38 | 6.65 | +26.0% | 7.11 | +17.9% |
| Total income | 528.77 | 530.13 | −0.3% | 552.41 | −4.3% |
| Profit before tax | 32.09 | 32.89 | −2.4% | 51.18 | −37.3% |
| Net profit for the period | 23.08 | 23.79 | −3.0% | 37.87 | −39.1% |
| EPS, basic (₹) | 3.93 | 4.05 | −3.0% | 6.45 | −39.1% |
| Net margin (%) | 4.4 | 4.5 | 6.9 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 520.39 | 523.48 | −0.6% | 545.30 | −4.6% |
| Other income | 8.38 | 6.64 | +26.2% | 7.11 | +17.9% |
| Total income | 528.77 | 530.12 | −0.3% | 552.41 | −4.3% |
| Profit before tax | 32.24 | 33.25 | −3.0% | 51.10 | −36.9% |
| Net profit for the period | 23.23 | 24.15 | −3.8% | 37.79 | −38.5% |
| EPS, basic (₹) | 3.96 | 4.12 | −3.9% | 6.44 | −38.5% |
| Net margin (%) | 4.5 | 4.6 | 6.9 |
Consolidated
- Filed with BSE
- 07 Feb 2024, 11:01 IST
- Board meeting
- 06 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Feb 2024, 11:01 IST
- Board meeting
- 06 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Audited
- Source
- XBRL filing on BSE